XML 66 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Variable Interest Entities (VIEs)
12 Months Ended
Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
VIE Assets
18.
Variable Interest Entities (VIEs) 
 
A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity’s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.
 
The Company’s VIEs include APC and other immaterial entities.
 
Assets recognized as a result of consolidating these VIEs do not represent additional assets that could be used to satisfy claims against the Company’s general assets. Conversely, liabilities recognized as a result of consolidating these VIEs do not represent additional claims on the Company’s general assets; rather, they represent claims against the specific assets of the VIE.
 
The Company evaluates its relationships with its VIEs on an ongoing basis to ensure that it continues to be the primary beneficiary.
 
The following table includes assets that can only be used to settle the liabilities of APC and the creditors of APC have no recourse to the Company. These assets and liabilities, with the exception of the investments in other entities – cost method and amounts due to affiliate, which are eliminated upon consolidation with the NMM, are included in the accompanying consolidated balance sheets. 
 
December 31,
 
2017
 
2016
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
54,686,370
 
$
42,452,619
 
Restricted cash – short-term
 
 
18,005,661
 
 
101,132
 
Fiduciary cash
 
 
2,017,437
 
 
1,050,739
 
Investment in marketable securities
 
 
1,057,090
 
 
1,051,807
 
Receivables, net
 
 
15,183,483
 
 
21,025,668
 
Prepaid expenses and other current assets
 
 
1,821,328
 
 
727,743
 
 
 
 
 
 
 
 
 
Total current assets
 
 
92,771,369
 
 
66,409,708
 
 
 
 
 
 
 
 
 
Noncurrent assets
 
 
 
 
 
 
 
Land, property and equipment, net
 
 
10,167,689
 
 
7,294,994
 
Intangible assets, net
 
 
70,841,907
 
 
84,473,335
 
Goodwill
 
 
60,012,316
 
 
56,213,448
 
Loans receivable – related parties
 
 
5,000,000
 
 
5,200,000
 
Loan receivable
 
 
5,000,000
 
 
-
 
Investments in other entities – equity method
 
 
21,903,524
 
 
24,256,065
 
Investments in other entities – cost method
 
 
4,320,000
 
 
4,320,000
 
Restricted cash – long-term
 
 
745,235
 
 
-
 
Other assets
 
 
1,371,664
 
 
1,596,848
 
 
 
 
 
 
 
 
 
Total noncurrent assets
 
 
179,362,335
 
 
183,354,690
 
 
 
 
 
 
 
 
 
Total assets
 
$
272,133,704
 
$
249,764,398
 
Current liabilities
 
 
 
 
 
 
 
Accounts payable and accrued expenses
 
$
3,625,610
 
$
4,213,551
 
Incentives payable
 
 
21,500,000
 
 
19,621,645
 
Fiduciary accounts payable
 
 
2,017,437
 
 
1,050,739
 
Medical liabilities
 
 
25,186,240
 
 
18,957,465
 
Income taxes payable
 
 
1,463,540
 
 
2,999,225
 
Amount due to affiliate
 
 
24,889,717
 
 
3,204,334
 
Bank loan, short-term
 
 
510,391
 
 
-
 
Capital lease obligations
 
 
98,738
 
 
-
 
 
 
 
 
 
 
 
 
Total current liabilities
 
 
79,291,673
 
 
50,046,959
 
 
 
 
 
 
 
 
 
Noncurrent liabilities
 
 
 
 
 
 
 
Deferred tax liability
 
 
20,970,766
 
 
36,148,696
 
Liability for unissued equity shares
 
 
1,185,025
 
 
1,008,925
 
Capital lease obligations, net of current portion
 
 
619,001
 
 
-
 
 
 
 
 
 
 
 
 
Total noncurrent liabilities
 
 
22,774,792
 
 
37,157,621
 
 
 
 
 
 
 
 
 
Total liabilities
 
$
102,066,465
 
$
87,204,580
 
 
The assets of our other consolidated VIEs were not considered significant.
 
Approximately $18,000,000 of restricted cash is related to an amount that, as a result of the merger between ApolloMed and NMM (see Note 3), is to be transferred into an escrow account that will be held for distribution to former NMM shareholders.